Seeman, Philip <br/><br/>
Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.  [electronic resource] 

 -  Synapse (New York, N.Y.)  Jan 2012 
 - 88-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-2396 
<br/><br/><label>Standard No.: </label>10.1002/syn.20987  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Binding, Competitive<br/>Corpus Striatum--drug effects<br/>Dopamine Agonists--pharmacokinetics<br/>Humans<br/>Protein Binding<br/>Radiopharmaceuticals--pharmacokinetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D2--metabolism<br/>Tritium